Unknown

Dataset Information

0

Ion Channels as Therapeutic Targets in High Grade Gliomas.


ABSTRACT: Glioblastoma multiforme (GBM) is a lethal brain cancer with an average survival of 14-15 months even with exhaustive treatment. High grade gliomas (HGG) represent the leading cause of CNS cancer-related death in children and adults due to the aggressive nature of the tumour and limited treatment options. The scarcity of treatment available for GBM has opened the field to new modalities such as electrotherapy. Previous studies have identified the clinical benefit of electrotherapy in combination with chemotherapeutics, however the mechanistic action is unclear. Increasing evidence indicates that not only are ion channels key in regulating electrical signaling and membrane potential of excitable cells, they perform a crucial role in the development and neoplastic progression of brain tumours. Unlike other tissue types, neural tissue is intrinsically electrically active and reliant on ion channels and their function. Ion channels are essential in cell cycle control, invasion and migration of cancer cells and therefore present as valuable therapeutic targets. This review aims to discuss the role that ion channels hold in gliomagenesis and whether we can target and exploit these channels to provide new therapeutic targets and whether ion channels hold the mechanistic key to the newfound success of electrotherapies.

SUBMITTER: Griffin M 

PROVIDER: S-EPMC7589494 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Ion Channels as Therapeutic Targets in High Grade Gliomas.

Griffin Michaela M   Khan Raheela R   Basu Surajit S   Smith Stuart S  

Cancers 20201021 10


Glioblastoma multiforme (GBM) is a lethal brain cancer with an average survival of 14-15 months even with exhaustive treatment. High grade gliomas (HGG) represent the leading cause of CNS cancer-related death in children and adults due to the aggressive nature of the tumour and limited treatment options. The scarcity of treatment available for GBM has opened the field to new modalities such as electrotherapy. Previous studies have identified the clinical benefit of electrotherapy in combination  ...[more]

Similar Datasets

| S-EPMC6380435 | biostudies-literature
| S-EPMC10224160 | biostudies-literature
| S-EPMC8783551 | biostudies-literature
| S-EPMC3280798 | biostudies-other
2021-12-15 | GSE161289 | GEO
| S-EPMC4046287 | biostudies-literature
| S-EPMC7472218 | biostudies-literature
| S-EPMC6325362 | biostudies-literature
| S-EPMC7592425 | biostudies-literature
| S-EPMC10050572 | biostudies-literature